Science Translational Medicine

Article	Citations
Stronger regulation of AI in biomedicine	496
A tale of two cells: Regulatory T cell–microglia cross-talk in the ischemic brain	400
Targeted partial reprogramming of age-associated cell states improves markers of health in mouse models of aging	313
Antigenic distance between primary and secondary dengue infections correlates with disease risk	290
Combination bezafibrate and nivolumab treatment of patients with advanced non–small cell lung cancer	236
Evolution of inflammation and immunity in a dengue virus 1 human infection model	221
Germline-encoded recognition of peanut underlies development of convergent antibodies in humans	213
TrkA-mediated sensory innervation of injured mouse tendon supports tendon sheath progenitor cell expansion and tendon repair	202
Integrated analysis of blood DNA methylation, genetic variants, circulating proteins, microRNAs, and kidney failure in type 1 diabetes	202
Transcriptome-based identification of tumor-reactive and bystander CD8 + T cell receptor clonotypes in human pancreatic cancer	202
Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome	200
A protein-free vaccine stimulates innate immunity and protects against nosocomial pathogens	191
Characterization of the SARS-CoV-2 B.1.621 (Mu) variant	190
AGER-dependent macropinocytosis drives resistance to KRAS-G12D–targeted therapy in advanced pancreatic cancer	190
Targeted genome editing restores auditory function in adult mice with progressive hearing loss caused by a human microRNA mutation	187
The rapid replacement of the SARS-CoV-2 Delta variant by Omicron (B.1.1.529) in England	187
Increased brain microvascular hemoglobin concentrations in children with cerebral malaria	186
Chronologically modified androgen receptor in recurrent castration-resistant prostate cancer and its therapeutic targeting	185
In vivo gene immunotherapy for cancer	180
SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery	178
Loss of miR-31-5p drives hematopoietic stem cell malignant transformation and restoration eliminates leukemia stem cells in mice	176
Podocyte YAP and TAZ hyperactivation drives glomerular epithelial proliferative diseases in mice and humans	167
Erratum for the Research Article: “Selectins impair regulatory T cell function and contribute to systemic lupus erythematosus pathogenesis” by M. Scherlinger, V. Guillotin, I. Douchet, P. Vacher, A. B	162
Inhaled remdesivir reduces viral burden in a nonhuman primate model of SARS-CoV-2 infection	159
Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR -mutant lung cancer	155

A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine	147
SHP2 promotes sarcoidosis severity by inhibiting SKP2-targeted ubiquitination of TBET in CD8 + T cells	143
Advancing beyond the twists and turns of T cell exhaustion in cancer	142
Metabolic reprogramming of skeletal muscle by resident macrophages points to CSF1R inhibitors as muscular dystrophy therapeutics	142
Early-set POMC methylation variability is accompanied by increased risk for obesity and is addressable by MC4R agonist treatment	142
Increased PDGFRB and NF-κB signaling caused by highly prevalent somatic mutations in intracranial aneurysms	142
Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment	141
Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies	141
Single-cell profiling of human bone marrow progenitors reveals mechanisms of failing erythropoiesis in Diamond-Blackfan anemia	135
Point-of-care diagnostic tests for tuberculosis disease	134
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer	134
A first-in-human study of the fibroblast activation protein–targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors	131
Engineering CAR-T therapies for autoimmune disease and beyond	128
Systemic administration of an RNA binding and cell-penetrating antibody targets therapeutic RNA to multiple mouse models of cancer	125
A risk model for digital breast tomosynthesis to predict breast cancer and guide clinical care	125
Sexually dimorphic differences in angiogenesis markers are associated with brain aging trajectories in humans	124
Nociceptor-to-macrophage communication through CGRP/RAMP1 signaling drives endometriosis-associated pain and lesion growth in mice	123
PET imaging of antisense oligonucleotide distribution in rat and nonhuman primate brains using click chemistry	122
The pancreatic clock is a key determinant of pancreatic fibrosis progression and exocrine dysfunction	122
Erratum for the Research Article: “The Role of Dimethylarginine Dimethylaminohydrolase in Idiopathic Pulmonary Fibrosis” by S. S. Pullamsetti, R. Savai, R. Dumitrascu, B. K. Dahal, J. Wilhelm, M. Koni	121
Rapid closure and hemostasis of ruptured soft tissues using a modified human tropoelastin-based sealant in preclinical models	119
BCKDHA-BCKDHB digenic gene therapy restores metabolic homeostasis in two mouse models and a calf with classic maple syrup urine disease	117
Improved control of a prosthetic limb by surgically creating electro-neuromuscular constructs with implanted electrodes	116
Development and preclinical validation of 2-deoxy 2-[ 18 F]fluorocellobiose as an Aspergillus -specific PET tracer	115
A human histidyl-tRNA synthetase splice variant therapeutic targets NRP2 to resolve lung inflammation and fibrosis	113
NAD + precursors and bile acid sequestration treat preclinical refractory environmental enteric dysfunction	112
TREM1 activation of myeloid cells promotes antitumor immunity	111
Follistatin drives neuropathic pain in mice through IGF1R signaling in nociceptive neurons	110
Integrating the gut microbiome and pharmacology	110
4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2 -encephalopathy	109
Ubiquitination and degradation of SUMO1 by small-molecule degraders extends survival of mice with patient-derived tumors	109
Decreased serotonin transporter activity in the mitral valve contributes to progression of degenerative mitral regurgitation	108
Hepatocyte CYR61 polarizes profibrotic macrophages to orchestrate NASH fibrosis	108
Genomic and epigenomic BRCA alterations predict adaptive resistance and response to platinum-based therapy in patients with triple-negative breast and ovarian carcinomas	107
The oncomodulin receptor ArmC10 enables axon regeneration in mice after nerve injury and neurite outgrowth in human iPSC–derived sensory neurons	107
Volumetric microscopy of cerebral arteries with a miniaturized optical coherence tomography imaging probe	106
Repeated COVID-19 mRNA-based vaccination contributes to SARS-CoV-2 neutralizing antibody responses in the mucosa	105
Translating insights into therapies for Long Covid	105
Molecular hallmarks of hydrocephalus	103
Next-generation CAR T cell therapies for glioblastoma	103
MEK1/2 inhibitors suppress pathological α-synuclein and neurotoxicity in cell models and a humanized mouse model of Parkinson’s disease	103
Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia	103
Pseudomonas aeruginosa infection induces intragraft lymphocytotoxicity that triggers lung transplant antibody-mediated rejection	103
Nonlesional lupus skin contributes to inflammatory education of myeloid cells and primes for cutaneous inflammation	102
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron	101
Disrupting mechanotransduction decreases fibrosis and contracture in split-thickness skin grafting	100
Ex silico engineering of cystine-dense peptides yielding a potent bispecific T cell engager	100
Targeting AKR1B1 inhibits glutathione de novo synthesis to overcome acquired resistance to EGFR-targeted therapy in lung cancer	99
Epitope base editing CD45 in hematopoietic cells enables universal blood cancer immune therapy	99
Targeted inducible delivery of immunoactivating cytokines reprograms glioblastoma microenvironment and inhibits growth in mouse models	98

Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)	98
Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer’s disease	97
Myeloid MAS–driven macrophage efferocytosis promotes resolution in ischemia-stressed mouse and human livers	95
Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort	95
Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment	94
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria	94
Postoperative adhesions are abrogated by a sustained-release anti-JUN therapeutic in preclinical models	94
mRNA therapy corrects defective glutathione metabolism and restores ureagenesis in preclinical argininosuccinic aciduria	93
Harnessing regulatory T cells to establish immune tolerance	92
Apelin stimulation of the vascular skeletal muscle stem cell niche enhances endogenous repair in dystrophic mice	92
Ebola virus persistence and disease recrudescence in the brains of antibody-treated nonhuman primate survivors	91
Calprotectin is a contributor to and potential therapeutic target for vascular calcification in chronic kidney disease	91
Repeated Plasmodium falciparum infection in humans drives the clonal expansion of an adaptive γδ T cell repertoire	91
Mitochondrial augmentation of hematopoietic stem cells in children with single large-scale mitochondrial DNA deletion syndromes	91
AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein–specific T H 1 response with a diverse TCR repertoire	90
Heterogeneity and evolution of DNA mutation rates in microsatellite stable colorectal cancer	90
Innate PD-L1 limits T cell–mediated adipose tissue inflammation and ameliorates diet-induced obesity	90
T cell receptor precision editing of regulatory T cells for celiac disease	89
Wastewater surveillance facilitates climate change–resilient pathogen monitoring	89
Adaptive cognitive control circuit changes associated with problem-solving ability and depression symptom outcomes over 24 months	88
Tobacco smoke exposure recruits inflammatory airspace monocytes that establish permissive lung niches for Mycobacterium tuberculosis	88
Diet shapes the metabolite profile in the intact human ileum, which affects PYY release	88
Astrocytic α2-Na + /K + ATPase inhibition suppresses astrocyte reactivity and reduces neurodegeneration in a tauopathy mouse model	87
The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants	87
Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial	87
A nose for tau	85
Obesity and lifespan, a complex tango	84
Farnesoid X receptor antagonizes macrophage-dependent licensing of effector T lymphocytes and progression of sclerosing cholangitis	84
Short-course combination treatment for experimental chronic Chagas disease	84
Assessment of cholesterol homeostasis in the living human brain	83
Peripheral expression of brain-penetrant progranulin rescues pathologies in mouse models of frontotemporal lobar degeneration	83
Transcriptomic sex differences in postmortem brain samples from patients with psychiatric disorders	82
CD23 + IgG1 + memory B cells are poised to switch to pathogenic IgE production in food allergy	81
Sirtuin 6 is required for the integrated stress response and resistance to inhibition of transcriptional cyclin-dependent kinases	81
A systems approach points to a therapeutic role for retinoids in asparaginase-associated pancreatitis	81
Metabolic surgery reduces CRC disease progression through circulating bile acid diversion	80
Erratum for the Research Article “A functional identification platform reveals frequent, spontaneous neoantigen-specific T cell responses in patients with cancer” by A. M. Miller et al<	79
Immune responses to gut bacteria associated with time to diagnosis and clinical response to T cell–directed therapy for type 1 diabetes prevention	79
Macrophage-specific in vivo RNA editing promotes phagocytosis and antitumor immunity in mice	79
Collagen V regulates renal function after kidney injury and can be pharmacologically targeted to enhance kidney repair in mice	79
SARS-CoV-2 induces neutrophil degranulation and differentiation into myeloid-derived suppressor cells associated with severe COVID-19	79
Green light analgesia in mice is mediated by visual activation of enkephalinergic neurons in the ventrolateral geniculate nucleus	79
Antibody Fc characteristics and effector functions correlate with protection from symptomatic dengue virus type 3 infection	78
Sex, lean body mass, and cardiac performance	78
A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models	78
IgE in allergy: It takes two	77
Treatment with ROS detoxifying gold quantum clusters alleviates the functional decline in a mouse model of Friedreich ataxia	77
Synthetic biology–driven induction of mature TLS formation enhances antitumor immunity in colorectal cancer	77
Targeting cytokines in inflammatory bowel disease	76
Piplartine attenuates aminoglycoside-induced TRPV1 activity and protects from hearing loss in mice	76
MicroRNA-142-3p shuttling in extracellular vesicles marks regulatory T cell dysfunction in multiple sclerosis	76
A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis	75
Nutrient-sensitizing drug repurposing screen identifies lomerizine as a mitochondrial metabolism inhibitor of chronic myeloid leukemia	75
T STEM -like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models	75
Antibody-mediated prevention of vaginal HIV transmission is dictated by IgG subclass in humanized mice	74
An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor	74
A randomized controlled trial showing safety and efficacy of a whole sporozoite vaccine against endemic malaria	74
Oral mucosal breaks trigger anti-citrullinated bacterial and human protein antibody responses in rheumatoid arthritis	74
Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencing	73
NFIA regulates articular chondrocyte fatty acid metabolism and joint homeostasis	72
A cell-penetrant peptide blocking C9ORF72 -repeat RNA nuclear export reduces the neurotoxic effects of dipeptide repeat proteins	72
Modeling injury and repair in kidney organoids reveals that homologous recombination governs tubular intrinsic repair	72
Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection	72
Tissue-resident CD8 + T cells drive compartmentalized and chronic autoimmune damage against CNS neurons	72
Simultaneous analysis of mutations and methylations in circulating cell-free DNA for hepatocellular carcinoma detection	71
Gut microbiome dysbiosis is associated with increased mortality after solid organ transplantation	71
Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non–small cell lung cancer	70
Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor–induced colitis	70
MR-guided focused ultrasound enhances delivery of trastuzumab to Her2-positive brain metastases	70
An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans	69
Albumin nanoparticle containing a PI3Kγ inhibitor and paclitaxel in combination with α-PD1 induces tumor remission of breast cancer in mice	69
A cross-talk established by tumor-targeted cytokines rescues CAR T cell activity and engages host T cells against glioblastoma in mice	69
Targeting ryanodine receptor type 2 to mitigate chemotherapy-induced neurocognitive impairments in mice	69
Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell–mediated antitumor immune response	68
Replication stress response defects are associated with response to immune checkpoint blockade in nonhypermutated cancers	68
Comment on “A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk”	68
Translating the evolving molecular landscape of tumors to biomarkers of response for cancer immunotherapy	68
Preexisting immunity to the 2009 pandemic H1N1 virus reduces susceptibility to H5N1 infection and disease in ferrets	68
Seeking satiety: From signals to solutions	67
In vivo Bruton’s tyrosine kinase inhibition attenuates alcohol-associated liver disease by regulating CD84-mediated granulopoiesis	67

Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic disease	67
Erratum for the Research Article “Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4” by Y. Ren et al .	67
Spatial genomics: Mapping the landscape of fibrosis	67
Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers	67
Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics	66
Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19	66
TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesis	65
Repeated Omicron exposures redirect SARS-CoV-2–specific memory B cell evolution toward the latest variants	65
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell–engaging bispecific antibody targeting human claudin 6	65
Resident microbes shape the vaginal epithelial glycan landscape	65
Human OX40L–CAR-T regs target activated antigen-presenting cells and control T cell alloreactivity	65
Neuroinflammation: An astrocyte perspective	65
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma	65
Erratum for the Research Article: “Maternal SARS-CoV-2 infection elicits sexually dimorphic placental immune responses” by E. A. Bordt, L. L. Shook, C. Atyeo, K. M. Pullen, R. M. De Guzman, M.-C. Mein	64
Delivery of therapeutic carbon monoxide by gas-entrapping materials	64
Blocking common γ chain cytokine signaling ameliorates T cell–mediated pathogenesis in disease models	64
An AAV gene therapy computes over multiple cellular inputs to enable precise targeting of multifocal hepatocellular carcinoma in mice	62
Dynamic PET-facilitated modeling and high-dose rifampin regimens for Staphylococcus aureus orthopedic implant–associated infections	62
Erratum for the Research Article “Platelet-derived growth factor C signaling is a potential therapeutic target for radiation proctopathy” by W. Lu et al .	62
Genipin rescues developmental and degenerative defects in familial dysautonomia models and accelerates axon regeneration	62
Interleukin-2–based therapies in cancer	62
New government drug repurposing programs: Opportunities and uncertainties	61
Prostate tissue ablation and drug delivery by an image-guided injectable ionic liquid in ex vivo and in vivo models	61
JUN promotes hypertrophic skin scarring via CD36 in preclinical in vitro and in vivo models	61
A germline SNP in BRMS1 predisposes patients with lung adenocarcinoma to metastasis and can be ameliorated by targeting c-fos	61
Expression of the excitatory opsin ChRERα can be traced longitudinally in rat and nonhuman primate brains with PET imaging	61
Identifying and targeting the Achilles heel of a recalcitrant cancer	60
Gastric dysfunction in patients with chronic nausea and vomiting syndromes defined by a noninvasive gastric mapping device	60
Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer	60
Targeting Src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models	60
Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer	60
Targeting a cell-specific microRNA repressor of CXCR4 ameliorates atherosclerosis in mice	60
NF-κB perturbation reveals unique immunomodulatory functions in Prx1 + fibroblasts that promote development of atopic dermatitis	59
Amyloid-associated hyperconnectivity drives tau spread across connected brain regions in Alzheimer’s disease	59
Allergy: Mechanistic insights into new methods of prevention and therapy	59
Flortaucipir PET uncovers relationships between tau and amyloid-β in primary age–related tauopathy and Alzheimer’s disease	59
Glioblastoma stem cells reprogram chromatin in vivo to generate selective therapeutic dependencies on DPY30 and phosphodiesterases	59
A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection	59
Single-cell atlas of human infrapatellar fat pad and synovium implicates APOE signaling in osteoarthritis pathology	58
Neuromodulation using ultra low frequency current waveform reversibly blocks axonal conduction and chronic pain	58
Gut microbiome composition may be an indicator of preclinical Alzheimer’s disease	58
Truncated titin proteins and titin haploinsufficiency are targets for functional recovery in human cardiomyopathy due toTTNmutations	58
Regulatory T cells attenuate chronic inflammation and cardiac fibrosis in hypertrophic cardiomyopathy	57
Targeting SIRT2 induces MLH1 deficiency and boosts antitumor immunity in preclinical colorectal cancer models	57
Response to Comment on “Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases”	57
Gut pathogen colonization precedes bloodstream infection in the neonatal intensive care unit	57
Learning CNS immunopathology from therapeutic interventions	56
Donor-derived regulatory dendritic cell infusion modulates effector CD8+T cell and NK cell responses after liver transplantation	56
Global spatial dynamics and vaccine-induced fitness changes of Bordetella pertussis	55
Altiratinib blocks Toxoplasma gondii and Plasmodium falciparum development by selectively targeting a spliceosome kinase	55
A mouse model of chronic primary pain that integrates clinically relevant genetic vulnerability, stress, and minor injury	55
Provocateurs of autoimmunity within the gut microbiota	54
Enhanced mTORC1 signaling and protein synthesis in pathologic α-synuclein cellular and animal models of Parkinson’s disease	54
Chemogenetics identifies separate area 25 brain circuits involved in anhedonia and anxiety in marmosets	54
Oxidative damage and delayed replication allow viable Mycobacterium tuberculosis to go undetected	54
A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2–specific immune responses in rhesus macaques	54
Vaccination with different group 2 influenza subtypes alters epitope targeting and breadth of hemagglutinin stem–specific human B cells	54
Where do the pathogens that cause surgical site infections come from?	53
Erratum for the Research Article “Boosting systemic absorption of peptides with a bioinspired buccal-stretching patch,” by Z. Luo et al .	53
Protein kinase Cι mediates immunosuppression in lung adenocarcinoma	53
Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model	52
Alpelisib administration reduced lymphatic malformations in a mouse model and in patients	52
Predicting the next round of drugs for Medicare price negotiation	52
T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19	52
Precise genomic editing of pathogenic mutations in RBM20 rescues dilated cardiomyopathy	52
Phenotypic screening with deep learning identifies HDAC6 inhibitors as cardioprotective in a BAG3 mouse model of dilated cardiomyopathy	52
Response to comment on “Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics”	52
Neuronal population activity in the olivocerebellum encodes the frequency of essential tremor in mice and patients	52
A prM mutation that attenuates dengue virus replication in human cells enhances midgut infection in mosquitoes	51
The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses	51
GABABreceptor modulation of visual sensory processing in adults with and without autism spectrum disorder	51
Activation and antitumor immunity of CD8 + T cells are supported by the glucose transporter GLUT10 and disrupted by lactic acid	51
Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer	51
Placental senescence pathophysiology is shared between peripartum cardiomyopathy and preeclampsia in mouse and human	51
Erratum for the Research Article “Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia” by R. Sartori et al .	50
Hindbrain octadecaneuropeptide gliotransmission as a therapeutic target for energy balance control without nausea or emesis	50
Triple knockdown of CD11a , CD49d , and PSGL1 in T cells reduces CAR-T cell toxicity but preserves activity	50
The protein kinase C modulator bryostatin-1 therapeutically targets microglia to attenuate neuroinflammation and promote remyelination	50
Human inner ear fluid imbalance detected by optical coherence tomography correlates with hearing loss	50
Glutamine promotes antibiotic uptake to kill multidrug-resistant uropathogenic bacteria	50
Population-level implications of the Israeli booster campaign to curtail COVID-19 resurgence	50
Keratinocytes: From passive targets to active mediators of systemic autoimmunity	50
Modeling lesion transition dynamics to clinically characterize patients with clade I mpox in the Democratic Republic of the Congo	50
An anti-mycobacterial conjugated oligoelectrolyte effective against Mycobacterium abscessus	50
Pathophysiology of Dyt1- Tor1a dystonia in mice is mediated by spinal neural circuit dysfunction	49
Hemodynamic evaluation of biomaterial-based surgery for Tetralogy of Fallot using a biorobotic heart, in silico, and ovine models	49
DeepHeme, a high-performance, generalizable deep ensemble for bone marrow morphometry and hematologic diagnosis	49
Myeloid cell–specific loss of NPC1 in mice recapitulates microgliosis and neurodegeneration in patients with Niemann-Pick type C disease	49
A semaphorin-plexin-Rasal1 signaling pathway inhibits gastrin expression and protects against peptic ulcers	49
Transient anti-interferon autoantibodies in the airways are associated with recovery from COVID-19	49
Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitis	49
The enhancer landscape predetermines the skeletal regeneration capacity of stromal cells	49
An identity crisis for lung cancer cells	48
A new chapter in lipid signaling and kidney fibrosis	48
Targeting the PDE3B-cAMP-autophagy axis prevents liver injury in long-term supercooling liver preservation	48